{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:54:35Z","timestamp":1787316875964,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015013","name":"Florida Department of State","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jid.2020.08.012","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T12:09:11Z","timestamp":1599048551000},"page":"840-851.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Noncanonical EphA2 Signaling Is a Driver of Tumor-Endothelial Cell Interactions and Metastatic Dissemination in BRAF Inhibitor\u2012Resistant Melanoma"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3424-871X","authenticated-orcid":false,"given":"Chao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6796-9145","authenticated-orcid":false,"given":"Inna","family":"Smalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0008-8335","authenticated-orcid":false,"given":"Michael F.","family":"Emmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8365-9916","authenticated-orcid":false,"given":"Ritin","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6467-9081","authenticated-orcid":false,"given":"Victoria","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0332-0224","authenticated-orcid":false,"given":"Jane","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3818-1762","authenticated-orcid":false,"given":"John M.","family":"Koomen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5076-4848","authenticated-orcid":false,"given":"Elena B.","family":"Pasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3756-8594","authenticated-orcid":false,"given":"Peter A.","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1089-9307","authenticated-orcid":false,"given":"Keiran S.M.","family":"Smalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2020.08.012_bib1","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1126\/science.275.5304.1308","article-title":"Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase","volume":"275","author":"Amano","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jid.2020.08.012_bib2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41571-019-0204-6","article-title":"Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFN\u03b3 pathways","volume":"16","author":"Bai","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jid.2020.08.012_bib3","doi-asserted-by":"crossref","first-page":"e50973","DOI":"10.1371\/journal.pone.0050973","article-title":"Resistance to fluid shear stress is a conserved biophysical property of malignant cells","volume":"7","author":"Barnes","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2020.08.012_bib4","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1158\/1940-6207.CAPR-09-0212","article-title":"EphA2 in the early pathogenesis and progression of non-small cell lung cancer","volume":"2","author":"Brannan","year":"2009","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.jid.2020.08.012_bib5","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1158\/1078-0432.CCR-14-1027","article-title":"Complete loss of PTEN protein expression correlates with shorter time to brain metastasis and survival in stage IIIB\/C melanoma patients with BRAFV600 mutations","volume":"20","author":"Bucheit","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2020.08.012_bib6","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.celrep.2015.09.057","article-title":"AKT1 activation promotes development of melanoma metastases","volume":"13","author":"Cho","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.jid.2020.08.012_bib7","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/cncr.25634","article-title":"Prognostic factors for survival in melanoma patients with brain metastases","volume":"117","author":"Davies","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.jid.2020.08.012_bib8","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1158\/1078-0432.CCR-09-1985","article-title":"Integrated molecular and clinical analysis of AKT activation in metastatic melanoma","volume":"15","author":"Davies","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2020.08.012_bib9","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1158\/0008-5472.CAN-19-0040","article-title":"HDAC8 regulates a stress response pathway in melanoma to mediate escape from BRAF inhibitor therapy","volume":"79","author":"Emmons","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2020.08.012_bib10","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/onc.2015.188","article-title":"Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E\/PTEN-null melanoma cells","volume":"35","author":"Fedorenko","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2020.08.012_bib11","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/CMR.0000000000000103","article-title":"Amuvatinib has cytotoxic effects against NRAS-mutant melanoma but not BRAF-mutant melanoma","volume":"24","author":"Fedorenko","year":"2014","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jid.2020.08.012_bib12","first-page":"773","article-title":"Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine","volume":"45","author":"Fidler","year":"1970","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jid.2020.08.012_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11060-015-1977-9","article-title":"Development of brain metastases in patients with metastatic melanoma while receiving ipilimumab","volume":"126","author":"Frenard","year":"2016","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.jid.2020.08.012_bib14","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.cub.2008.08.053","article-title":"DOCK10-mediated Cdc42 activation is necessary for amoeboid invasion of melanoma cells","volume":"18","author":"Gadea","year":"2008","journal-title":"Curr Biol"},{"key":"10.1016\/j.jid.2020.08.012_bib15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1158\/2159-8290.CD-12-0386","article-title":"Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma","volume":"3","author":"Girotti","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jid.2020.08.012_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/cam4.1267","article-title":"Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanoma","volume":"7","author":"Hassel","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.jid.2020.08.012_bib17","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.cell.2015.07.061","article-title":"Non-genomic and immune evolution of melanoma acquiring MAPKi resistance","volume":"162","author":"Hugo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jid.2020.08.012_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194170","article-title":"Fluid shear stress impacts ovarian cancer cell viability, subcellular organization, and promotes genomic instability","volume":"13","author":"Hyler","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2020.08.012_bib19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/107327481302000407","article-title":"Novel treatments for melanoma brain metastases","volume":"20","author":"Kenchappa","year":"2013","journal-title":"Cancer Control"},{"key":"10.1016\/j.jid.2020.08.012_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.273.5272.245","article-title":"Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)","volume":"273","author":"Kimura","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jid.2020.08.012_bib21","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ccr.2012.10.009","article-title":"Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas","volume":"22","author":"Lito","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2020.08.012_bib22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1158\/2159-8290.CD-14-0295","article-title":"EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanoma","volume":"5","author":"Miao","year":"2015","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jid.2020.08.012_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2009.04.009","article-title":"EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt","volume":"16","author":"Miao","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2020.08.012_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ccell.2019.12.003","article-title":"Myosin II reactivation and cytoskeletal remodeling as a hallmark and a vulnerability in melanoma therapy resistance","volume":"37","author":"Orgaz","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2020.08.012_bib25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/2159-8290.CD-14-0293","article-title":"Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype","volume":"5","author":"Paraiso","year":"2015","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jid.2020.08.012_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrc2806","article-title":"Eph receptors and ephrins in cancer: bidirectional signalling and beyond","volume":"10","author":"Pasquale","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2020.08.012_bib27","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nrc3628","article-title":"Crossing the endothelial barrier during metastasis","volume":"13","author":"Reymond","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2020.08.012_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0092-8674(92)90164-8","article-title":"The small GTP-binding protein rac regulates growth factor-induced membrane ruffling","volume":"70","author":"Ridley","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.jid.2020.08.012_bib29","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nrc2229","article-title":"Illuminating the metastatic process","volume":"7","author":"Sahai","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2020.08.012_bib30","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ncb1019","article-title":"Differing modes of tumour cell invasion have distinct requirements for Rho\/ROCK signalling and extracellular proteolysis","volume":"5","author":"Sahai","year":"2003","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jid.2020.08.012_bib31","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.cell.2008.09.043","article-title":"Rac activation and inactivation control plasticity of tumor cell movement","volume":"135","author":"Sanz-Moreno","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jid.2020.08.012_bib32","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1021\/acs.jproteome.6b00613","article-title":"Activity-based protein profiling shows heterogeneous signaling adaptations to BRAF inhibition","volume":"15","author":"Sharma","year":"2016","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.jid.2020.08.012_bib33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ebiom.2019.09.023","article-title":"Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma","volume":"48","author":"Smalley","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jid.2020.08.012_bib34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1097-0045(19991201)41:4<275::AID-PROS8>3.0.CO;2-T","article-title":"Overexpression of the EphA2 tyrosine kinase in prostate cancer","volume":"41","author":"Walker-Daniels","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/j.jid.2020.08.012_bib35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ncb1230","article-title":"Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion","volume":"7","author":"Wilkinson","year":"2005","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jid.2020.08.012_bib36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1083\/jcb.200209006","article-title":"Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis","volume":"160","author":"Wolf","year":"2003","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.jid.2020.08.012_bib37","first-page":"2301","article-title":"EphA2 overexpression causes tumorigenesis of mammary epithelial cells","volume":"61","author":"Zelinski","year":"2001","journal-title":"Cancer Res"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20320479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20320479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:20:17Z","timestamp":1758302417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X20320479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0022202X20320479"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2020.08.012","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noncanonical EphA2 Signaling Is a Driver of Tumor-Endothelial Cell Interactions and Metastatic Dissemination in BRAF Inhibitor\u2012Resistant Melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2020.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}